News Focus
News Focus
icon url

StonkMaster

10/22/24 2:31 PM

#727793 RE: CrashOverride #727791

Would love to hear your thoughts on who the BP partner(s) will be and in what capacity.
icon url

exwannabe

10/22/24 2:43 PM

#727795 RE: CrashOverride #727791

No doubt the Casgevy NICE guidance was super fast.

That said, the company evidence submission was June 2023 (well before MHRA approval, despite what some "experts" say is possible) and the guidance was issued March 2024, only 9 months after the evidence submission and 5 months after approval.

I would also not that the submitter was a BP (Vertex), that helps a lot as they know what is needed to do it right.